強気
$44.49
シナリオ価格
$53.660
-1.782 (-3.32%)終値時点
CNO Financial Group, Inc. is a holding company for a group of insurance companies. It provides life and health insurance, annuities, financial services and workforce benefits solutions through its family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. It is focused on serving middle-income pre-retiree and retired Americans. It markets its products through the Consumer and Worksite Divisions that reflect the customers served by the Company. The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on the sale of voluntary benefit life and health insurance products in the workplace for businesses, associations and other membership groups, interacting with customers at their place of employment and virtually. It also offers a suite of voluntary benefits, benefits administration technology and advocacy services.
CNO Financial Group is a good buy right now due to its strong earnings growth and optimistic outlook. The current price is $53.66, and the company reported a 45% year-over-year increase in operating earnings per share to $1.26 in Q2 2026, along with a raised full-year EPS guidance to between $4.60 and $4.80. However, the RSI is at 39.803, indicating that the stock is nearing oversold territory, which presents a potential buying opportunity. The main risk is the high P/E ratio of 42.8, which suggests that the stock may be overvalued if earnings do not continue to grow as expected.
Evercore ISI
$48
2026-06-01
Evercore ISI
2026-06-01
目標株価
$48
Keefe Bruyette
$50
2026-05-05
Keefe Bruyette
2026-05-05
目標株価
$50
Keefe Bruyette
$46
2026-03-26
Keefe Bruyette
2026-03-26
目標株価
$46
Evercore ISI
$43
2026-02-18
Evercore ISI
2026-02-18
目標株価
$43
Piper Sandler
$50
2025-12-23
Piper Sandler
2025-12-23
目標株価
$50
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Indiana's Marathon Weekend Welcomes Global Participants

CNO Financial Group to Report Q3 Results on October 29, 2026

CNO Financial Group CEO to Speak at Insurance Conference

CNO Financial (CNO) Q2 2026 Earnings Call Transcript

CNO Financial Group Reports Strong Q2 2026 Earnings Growth
CNO Financial Group, Inc. is a holding company for a group of insurance companies. It provides life and health insurance, annuities, financial services and workforce benefits solutions through its family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. It is focused on serving middle-income pre-retiree and retired Americans. It markets its products through the Consumer and Worksite Divisions that reflect the customers served by the Company. The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on the sale of voluntary benefit life and health insurance products in the workplace for businesses, associations and other membership groups, interacting with customers at their place of employment and virtually. It also offers a suite of voluntary benefits, benefits administration technology and advocacy services. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).
CNO Financial Group is a good buy right now due to its strong earnings growth and optimistic outlook. The current price is $53.66, and the company reported a 45% year-over-year increase in operating earnings per share to $1.26 in Q2 2026, along with a raised full-year EPS guidance to between $4.60 and $4.80. However, the RSI is at 39.803, indicating that the stock is nearing oversold territory, which presents a potential buying opportunity. The main risk is the high P/E ratio of 42.8, which suggests that the stock may be overvalued if earnings do not continue to grow as expected.
8 analysts cover CNO: 1 rate it Buy, 6 Hold and 1 Sell. The average price target is 48.00.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。